相关实验视频
Updated: Jun 23, 2025

10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
21.6K
纤维素素与激活的血小板结合,以及其生物模拟血栓向的血栓解毒策略
Yu Huang1, Jiahua Wang1, Yuanyuan Guo1
1Department of Radiology, Shanghai Jiao Tong University School of Medicine Affiliated Shanghai Sixth People's Hospital, 600 Yi Shan Road, Shanghai 200233, PR China.
International journal of biological macromolecules
|June 22, 2024
概括
针对血小板-纤维素因子相互作用的生物仿真策略可以改善血栓溶解. 这种方法可以提高药物输送到血栓,克服当前治疗中风和心脏病发作等疾病的局限性.
科学领域:
- 生物医学工程 生物医学工程
- 血栓形成研究研究
- 药物输送系统 药物输送系统
背景情况:
- 导致中风和心脏病发作的血栓形成,由于目前的血栓消毒疗法局限性,造成了重大临床挑战.
- 血小板和纤维素是凝块形成的核心,使它们成为新型治疗策略的关键目标.
- 现有的血栓溶解疗法缺乏特异性,导致潜在的安全问题和有效性降低.
研究的目的:
- 审查血栓形成背后的分子机制,重点关注血小板-纤维素原相互作用.
- 引入和讨论由这些相互作用启发的生物模拟血栓向的血栓解毒策略.
- 突出针对性血栓溶解的最新进展和未来前景.
主要方法:
- 血小板和纤维素原的概述特征.
- 审查了血栓形成的经典分子机制 (粘附,激活,聚合).
- 强调了生物仿真血栓溶解策略的近期进展.
主要成果:
- 血小板-纤维素原结合是血栓形成的一个关键途径.
- 生物仿真策略可以选择性地向血栓部位的活性血小板.
- 有针对性的输送增强了血栓解毒剂的局部释放,以提高疗效.
结论:
- 生物仿真血栓向策略显示出更安全,更有效的血栓溶解的前景.
- 了解血小板-纤维素原相互作用对于开发先进的治疗方法至关重要.
- 在这个新兴领域进行进一步的研究可能会在治疗血栓性疾病方面取得显著的临床进展.
相关概念视频
Clot Retraction and Fibrinolysis
5.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
Formation of the Platelet Plug
5.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.8K
Extrinsic and Intrinsic Pathways of Hemostasis
7.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.1K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
517
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
517
Introduction to Hemostasis
7.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.2K

